Login Register Cart 0
Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Homocysteine, Vitamin B12 and Folate Level: Possible Risk Factors in the Progression of Chronic Heart and Kidney Disorders

Author(s): Aditi Mohan, Ravi Kumar, Vivek Kumar and Mahendra Yadav*

Volume 19, Issue 4, 2023

Published on: 30 March, 2023

Article ID: e090223213539 Pages: 18

DOI: 10.2174/1573403X19666230209111854

Price: $65

Abstract

Cobalamin is an essential molecule for humans; it is exceptionally important for various body functions, including deoxyribonucleic acid synthesis and cellular energy production. Vegans are more vulnerable to vitamin B12 deficiency than natives with moderate consumption of animal dietary supplements or people with inadequate nutritional patterns. However, the long-term effects of sub-medical deficiency have not been thoroughly studied, but they may have a negative impact on the cardiovascular system, pregnancy outcomes, and vascular, renal, cognitive, bone, and eye health. Alongside the statin remedy, that is a powerful approach for CVD prevention. Another approach is related to the B nutrition substitution remedy with folic acid, and vitamins B6 and B12 are extensively practised nowadays. There is a tremendous interest in plasma homocysteine (tHcy) as a cardiovascular hazard factor. However, current research in the field of its prevention is more inclined toward confirming the benefit of tHcy-reducing remedy with vitamin B12. Thus, while folic acid fortification is primarily aimed at reducing neural-tube defects, it may also play a significant role in the primary prevention of CVD by lowering tHcy. Folate and B-vitamins play important roles in CVD prevention and nutrition policy implementation. Patients affected with Chronic Kidney Disease (CKD) or end-stage Stage Renal Disease (ESRD) experience a tremendous cardiovascular threat that may also further lead to death. As a result, routine monitoring of vitamin B12 levels is likely to be beneficial for the early detection and treatment of metabolic vitamin B12 deficiency, as well as the prevention of heart-related diseases.

Keywords: Homocysteine, Vitamin B12, chronic kidney disease, cardiovascular system, cobalamin, ESRD.

Graphical Abstract

[1]
Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013; 61(4): 289-94.
[http://dx.doi.org/10.1016/j.jjcc.2012.11.009] [PMID: 23473764]
[2]
Hansen CS, Jensen JS, Ridderstråle M, Vistisen D, Jørgensen ME, Fleischer J. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications 2017; 31(1): 202-8.
[http://dx.doi.org/10.1016/j.jdiacomp.2016.08.025] [PMID: 27638143]
[3]
Cerit L. Plant-based diet and vitamin B12. Cardiol J 2016; 23(5): 586.
[http://dx.doi.org/10.5603/CJ.2016.0080] [PMID: 27723058]
[4]
Collins AJ, Foley RN, Chavers B, et al. US renal data system 2013 annual data report. Am J Kidney Dis 2014; 63(1): A7.
[http://dx.doi.org/10.1053/j.ajkd.2013.11.001] [PMID: 24360288]
[5]
Freeman AM, Morris PB, Aspry K, et al. A clinician’s guide for trending cardiovascular nutrition controversies. J Am Coll Cardiol 2018; 72(5): 553-68.
[http://dx.doi.org/10.1016/j.jacc.2018.05.030] [PMID: 30049315]
[6]
Sahin-Uysal N, Gulumser C, Kocaman E, Varan B, Bayraktar N. Yanık F. Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: A case-control study. J Matern Fetal Neonatal Med 2020; 33(15): 2649-56.
[http://dx.doi.org/10.1080/14767058.2019.1633300] [PMID: 31256695]
[7]
Lederer AK, Hannibal L, Hettich M, et al. Vitamin B12 status upon short-term intervention with a vegan diet-a randomized controlled trial in healthy participants. Nutrients 2019; 11(11): 2815.
[http://dx.doi.org/10.3390/nu11112815] [PMID: 31752105]
[8]
Debreceni B, Debreceni L. Role of vitamins in cardiovascular health and disease. Res Rep Clinic Cardiol 2014; 5: 283-95.
[http://dx.doi.org/10.2147/RRCC.S44465]
[9]
Capelli I, Cianciolo G, Gasperoni L, et al. Folic acid and vitamin B12 administration in ckd, why not? Nutrients 2019; 11(2): 383.
[http://dx.doi.org/10.3390/nu11020383] [PMID: 30781775]
[10]
Zhang C, Wang ZY, Qin YY, Yu FF, Zhou YH. Association between B vitamins supplementation and risk of cardiovascular outcomes: A cumulative meta-analysis of randomized controlled trials. PLoS One 2014; 9(9): e107060.
[http://dx.doi.org/10.1371/journal.pone.0107060] [PMID: 25238614]
[11]
Fröhlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: Looking beyond primary PCI. Eur Heart J 2013; 34(23): 1714-22.
[http://dx.doi.org/10.1093/eurheartj/eht090] [PMID: 23536610]
[12]
Chuang CH, Lee YY, Sheu BF, et al. Homocysteine and C-reactive protein as useful surrogate markers for evaluating CKD risk in adults. Kidney Blood Press Res 2013; 37(4-5): 402-13.
[http://dx.doi.org/10.1159/000355722] [PMID: 24247268]
[13]
Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort. J Nephrol 2019; 32(5): 783-9.
[http://dx.doi.org/10.1007/s40620-019-00618-x] [PMID: 31165981]
[14]
Perna AF, Di Nunzio A, Amoresano A, et al. Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients. Biochimie 2016; 126: 97-107.
[http://dx.doi.org/10.1016/j.biochi.2016.04.018] [PMID: 27129884]
[15]
Spence JD, Urquhart BL, Bang H. Effect of renal impairment on atherosclerosis: Only partially mediated by homocysteine. Nephrol Dial Transplant 2016; 31(6): 937-44.
[http://dx.doi.org/10.1093/ndt/gfv380] [PMID: 26567910]
[16]
Cianciolo G, De Pascalis A, Di Lullo L, Ronco C, Zannini C, La Manna G. Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: Which comes first. Cardiorenal Med 2017; 7(4): 255-66.
[http://dx.doi.org/10.1159/000471813] [PMID: 29118764]
[17]
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One 2016; 11(7): e0158765.
[http://dx.doi.org/10.1371/journal.pone.0158765] [PMID: 27383068]
[18]
Bourrier M, Ferguson TW, Embil JM, Rigatto C, Komenda P, Tangri N. Peripheral artery disease: Its adverse consequences with and without CKD. Am J Kidney Dis 2020; 75(5): 705-12.
[http://dx.doi.org/10.1053/j.ajkd.2019.08.028] [PMID: 31879218]
[19]
Ahn TK, Kim J, Kim H, et al. 3′-UTR polymorphisms of MTHFR and TS associated with osteoporotic vertebral compression fracture susceptibility in postmenopausal women. Int J Mol Sci 2018; 19(3): 824.
[http://dx.doi.org/10.3390/ijms19030824] [PMID: 29534533]
[20]
Long Y, Nie J. Homocysteine in renal injury. Kidney Dis 2016; 2(2): 80-7.
[http://dx.doi.org/10.1159/000444900] [PMID: 27536696]
[21]
McMahon GM, Hwang SJ, Tanner RM, et al. The association between vitamin B12, albuminuria and reduced kidney function: an observational cohort study. BMC Nephrol 2015; 16(1): 7.
[http://dx.doi.org/10.1186/1471-2369-16-7] [PMID: 25644490]
[22]
Rizzo G, Laganà A, Rapisarda A, et al. Vitamin B12 among vegetarians: Status, assessment and supplementation. Nutrients 2016; 8(12): 767.
[http://dx.doi.org/10.3390/nu8120767] [PMID: 27916823]
[23]
Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002; 288(16): 2015-22.
[http://dx.doi.org/10.1001/jama.288.16.2015] [PMID: 12387654]
[24]
Shivkar RR, Gawade GC, Padwal MK, Diwan AG, Mahajan SA, Kadam CY. Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) polymorphisms with serum homocysteine, folate and vitamin B12 in patients with young coronary artery disease. Indian J Clin Biochem 2022; 37(2): 224-31.
[http://dx.doi.org/10.1007/s12291-021-00982-1] [PMID: 35463099]
[25]
Jadavji NM, Yahn GB, Abato JE. Role of vitamin B12 deficiency in ischemic stroke risk and outcome. Neural Regen Res 2021; 16(3): 470-4.
[http://dx.doi.org/10.4103/1673-5374.291381] [PMID: 32985467]
[26]
Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases. Eur J Med Genet 2015; 58(1): 1-10.
[http://dx.doi.org/10.1016/j.ejmg.2014.10.004] [PMID: 25449138]
[27]
Ostrakhovitch EA, Tabibzadeh S. Homocysteine and age-associated disorders. Ageing Res Rev 2016; 49: 144-64.
[http://dx.doi.org/10.1016/j.arr.2018.10.010] [PMID: 27723058]
[28]
Jakubowski H. Homocysteine modification in protein structure/function and human disease. Physiol Rev 2019; 99(1): 555-604.
[http://dx.doi.org/10.1152/physrev.00003.2018] [PMID: 30427275]
[29]
Wang X, Demirtas H, Xu X. Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med 2006; 355(2): 207-9.
[PMID: 16838445]
[30]
Spence JD. Metabolic vitamin B12 deficiency: A missed opportunity to prevent dementia and stroke. Nutr Res 2016; 36(2): 109-16.
[http://dx.doi.org/10.1016/j.nutres.2015.10.003] [PMID: 26597770]
[31]
Pawlak R. Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians? Am J Prev Med 2015; 48(6): e11-26.
[http://dx.doi.org/10.1016/j.amepre.2015.02.009] [PMID: 25998928]
[32]
Zhang R, Guo L, Zhao D, Qu P, Dang S, Yan H. Maternal B-vitamin intake and B-vitamin supplementation during pregnancy in relation to neonatal congenital heart defects: A case-control study with propensity score matching. Eur J Clin Nutr 2021; 75(5): 782-91.
[http://dx.doi.org/10.1038/s41430-020-00804-2] [PMID: 33199851]
[33]
Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed 2018; 89(8-S): 88-92.
[http://dx.doi.org/10.23750/abm.v89i8-S.7921] [PMID: 30561424]
[34]
Spence J. Nutrition and risk of stroke. Nutrients 2019; 11(3): 647.
[http://dx.doi.org/10.3390/nu11030647] [PMID: 30884883]
[35]
a) Su R, Huang Y, Zhang DG, Xiao G, Wei L. SRDFM: Siamese response deep factorization machine to improve anti-cancer drug recommendation. Brief Bioinform 2022; 23(2): bbab534.
[http://dx.doi.org/10.1093/bib/bbab534] [PMID: 35043144];
b) Spence JD. Recent advances in preventing recurrent stroke. Fac Rev 2020; 9: F1000-12.
[http://dx.doi.org/10.12688/f1000research.23199.1] [PMID: 32864099]
[36]
Polytarchou K, Dimitroglou Y, Varvarousis D, et al. Methylmalonic acid and vitamin B12 in patients with heart failure. Hellenic J Cardiol 2020; 61(5): 330-7.
[http://dx.doi.org/10.1016/j.hjc.2019.10.010] [PMID: 31740360]
[37]
van der Wal HH, Comin-Colet J, Klip IT, et al. Vitamin B12 and folate deficiency in chronic heart failure. Heart 2015; 101(4): 302-10.
[http://dx.doi.org/10.1136/heartjnl-2014-306022] [PMID: 25324534]
[38]
Obeid R, Holzgreve W, Pietrzik K. Folate supplementation for prevention of congenital heart defects and low birth weight: an update. Cardiovasc Diagn Ther 2019; 9(S2) (Suppl. 2): S424-33.
[http://dx.doi.org/10.21037/cdt.2019.02.03] [PMID: 31737547]
[39]
Takagi H, Umemoto T. Vitamins and abdominal aortic aneurysm. Int Angiol 2017; 36(1): 21-30.
[http://dx.doi.org/10.23736/S0392-9590.16.03618-X] [PMID: 26603433]
[40]
Angelini A, Cappuccilli ML, Magnoni G, et al. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol 2021; 38(4): 2021-vol4.
[PMID: 34469084]
[41]
Wu HHL, Wang AYM. Vitamin B12 and chronic kidney disease. Vitam Horm 2022; 119: 325-53.
[http://dx.doi.org/10.1016/bs.vh.2022.01.011] [PMID: 35337625]
[42]
Sukla KK, Raman R. Association of MTHFR and RFC1 gene polymorphism with hyperhomocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population. Eur J Clin Nutr 2012; 66(1): 111-8.
[http://dx.doi.org/10.1038/ejcn.2011.152] [PMID: 21878957]
[43]
Barnabé A, Aléssio ACM, Bittar LF, et al. Folate, Vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center. Nutr J 2015; 14(1): 19.
[http://dx.doi.org/10.1186/s12937-015-0006-3] [PMID: 25886278]
[44]
Fu L, Li Y, Luo D, Deng S, Wu B, Hu YQ. Evidence on the causal link between homocysteine and hypertension from a meta‐analysis of 40 173 individuals implementing mendelian randomization. J Clin Hypertens 2019; 21(12): 1879-94.
[http://dx.doi.org/10.1111/jch.13737] [PMID: 31769183]
[45]
BrezovskaKavrakova J. Krstevska M, Bosilkova G, Alabakovska S, Panov S, Orovchanec N. Hyperhomocysteinemia and of methylenetetrahydrofolate reductase (c677t) genetic polymorphism in patients with deep vein thrombosis. Mater Sociomed 2013; 25(3): 170-4.
[http://dx.doi.org/10.5455/msm.2013.25.170-174] [PMID: 24167429]
[46]
Ni J, Zhang L, Zhou T, et al. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan province, China. J Chin Med Assoc 2017; 80(3): 147-53.
[http://dx.doi.org/10.1016/j.jcma.2016.07.005] [PMID: 28094233]
[47]
Kumar P, Mishra A, Prasad MK, Verma V, Kumar A. Relationship of Methylenetetrahydrofolate Reductase (MTHFR) C677T variation with susceptibility of patients with ischemic stroke: A meta-analysis. Cureus 2022; 14(8): e28218.
[http://dx.doi.org/10.7759/cureus.28218] [PMID: 36017481]
[48]
Fu L, Li YN, Luo D, Deng S, Wu B, Hu YQ. Evidence on the causal link between homocysteine and hypertension from a metaanalysis of 40 173 individuals implementing Mendelian randomization. J Clin Hypertens (Greenwich) 2019; 21(12): 1879-1894.
[http://dx.doi.org/10.1111/jch.13737] [PMID: 31769183] [PMCID: PMC8030561]
[49]
Brezovska-Kavrakova J, Krstevska M, Bosilkova G, Alabakovska S, Panov S, Orovchanec N. Hyperhomocysteinemia and of Methylenetetrahydrofolate Reductase (C677T) Genetic Polymorphism in Patients with Deep Vein Thrombosis. Mater Sociomed 2013; 25(3): 170-4.
[http://dx.doi.org/10.5455/msm.2013.25.170-174] [PMID: 24167429] [http://dx.doi.org/10.1007/s40620-014-0126-4] [PMID: 25095762]
[50]
Gholipur-Shahraki T, Badri S, Vahdat S, Seirafian S, Pourfarzam M, Ataei S. Homocysteine-lowering interventions in chronic kidney disease. J Res Pharm Pract 2021; 10(3): 114-24.
[http://dx.doi.org/10.4103/jrpp.jrpp_75_21] [PMID: 35198504]
[51]
Nigwekar SU, Kang A, Zoungas S, et al. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Libr 2016; 2016(5): CD004683.
[http://dx.doi.org/10.1002/14651858.CD004683.pub4] [PMID: 27243372]
[52]
Biselli JM, Machado FB, Zampieri BL, et al. Double aneuploidy (48,XXY,+21) of maternal origin in a child born to a 13-year-old mother: evaluation of the maternal folate metabolism. Genet Couns 2009; 20(3): 225-34.
[PMID: 19852428] [http://dx.doi.org/10.1161/01.CIR.0000114133.99074.96] [PMID: 14744952]
[53]
Suliman ME, Lindholm B, Bárány P, Qureshi AR, Stenvinkel P. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients. Semin Dial 2007; 20(6): 523-9.
[http://dx.doi.org/10.1111/j.1525-139X.2007.00336.x] [PMID: 17991198]
[54]
Heinz J, Kropf S, Luley C, Dierkes J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis 2009; 54(3): 478-89.
[http://dx.doi.org/10.1053/j.ajkd.2009.01.266] [PMID: 19359080]
[55]
Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Libr 2017; 2021(9): CD006612.
[http://dx.doi.org/10.1002/14651858.CD006612.pub5] [PMID: 28816346]
[56]
Kang A, Nigwekar SU, Perkovic V, et al. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Libr 2015; (5): CD007910.
[http://dx.doi.org/10.1002/14651858.CD007910.pub2] [PMID: 25938479]
[57]
Raval AD, Thakker D, Rangoonwala AN, Gor D, Walia R. Vitamin B and its derivatives for diabetic kidney disease. Cochrane Libr 2015; 1: CD009403.
[http://dx.doi.org/10.1002/14651858.CD009403.pub2] [PMID: 25579852]
[58]
Liu M, Li XC, Lu L, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 2014; 18(19): 2918-26.
[PMID: 25339487]
[59]
Flores-Guerrero JL, Minovic I, Groothof D, et al. Association of plasma concentration of vitamin B12 with all-cause mortality in the general population in the netherlands. JAMA Netw Open 2020; 3(1): e1919274.
[http://dx.doi.org/10.1001/jamanetworkopen.2019.19274] [PMID: 31940038]
[60]
Xu K, Liu X, Liu J, et al. Association between serum vitamin B12 and risk of all-cause mortality in elderly adults: a prospective cohort study. BMC Geriatr 2021; 21(1): 497.
[http://dx.doi.org/10.1186/s12877-021-02443-z] [PMID: 34530742]
[61]
Liu Y, Geng T, Wan Z, et al. Associations of serum folate and vitamin B 12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open 2022; 5(1): e2146124.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.46124] [PMID: 35099545]
[62]
Afriyie-Gyawu E, Ifebi E, Ampofo-Yeboah A, Kyte B, Shrestha S, Zhang J. Serum folate levels and fatality among diabetic adults: A 15-y follow-up study of a national cohort. Nutrition 2016; 32(4): 468-73.
[http://dx.doi.org/10.1016/j.nut.2015.10.021] [PMID: 26746677]
[63]
Bo Y, Xu H, Zhang H, et al. Intakes of folate, vitamin B6, and vitamin B12 in relation to all-cause and cause-specific mortality: A national population-based cohort. Nutrients 2022; 14(11): 2253.
[http://dx.doi.org/10.3390/nu14112253] [PMID: 35684053]
[64]
Kumar KA, Lalitha A, Pavithra D, et al. Maternal dietary folate and/or vitamin B12 restrictions alter body composition (adiposity) and lipid metabolism in Wistar rat offspring. J Nutr Biochem 2013; 24(1): 25-31.
[http://dx.doi.org/10.1016/j.jnutbio.2012.01.004] [PMID: 22703962]
[65]
Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: A mini review. Expert Rev Cardiovasc Ther 2018; 16(8): 559-65.
[http://dx.doi.org/10.1080/14779072.2018.1497974] [PMID: 29979619]
[66]
Wang MC, Lin CC, Chiang HY, et al. Association between coronary artery calcium and all-cause mortality: A large single-center retrospective cohort study. PLoS One 2022; 17(10): e0276659.
[http://dx.doi.org/10.1371/journal.pone.0276659] [PMID: 36288331]
[67]
Shih YL, Shih CC, Chen JY. Elevated homocysteine level as an indicator for chronic kidney disease in community-dwelling middle-aged and elderly populations in Taiwan: A community-based cross-sectional study. Front Med 2022; 9: 964101.
[http://dx.doi.org/10.3389/fmed.2022.964101] [PMID: 36004372]
[68]
Paganelli F, Mottola G, Fromonot J, et al. Hyperhomocysteinemia and cardiovascular disease: is the adenosinergic system the missing link? Int J Mol Sci 2021; 22(4): 1690.
[http://dx.doi.org/10.3390/ijms22041690] [PMID: 33567540]
[69]
Rallidis LS, Kosmas N, Rallidi T, Pavlakis G, Kiouri E, Zolindaki M. Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins. Coron Artery Dis 2020; 31(2): 152-6.
[http://dx.doi.org/10.1097/MCA.0000000000000800] [PMID: 31609754]
[70]
Kaye AD, Jeha GM, Pham AD, et al. Folic acid supplementation in patients with elevated homocysteine levels. Adv Ther 2020; 37(10): 4149-64.
[http://dx.doi.org/10.1007/s12325-020-01474-z] [PMID: 32845472]
[71]
Campbell MS, Ouyang A, Krishnakumar IM, Charnigo RJ, Westgate PM, Fleenor BS. Influence of enhanced bioavailable curcumin on obesity-associated cardiovascular disease risk factors and arterial function: A double-blinded, randomized, controlled trial. Nutrition 2019; 62: 135-9.
[http://dx.doi.org/10.1016/j.nut.2019.01.002] [PMID: 30889454]
[72]
Ma WJ, Qin M, Cui TW, et al. Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case-control study. Transl Androl Urol 2021; 10(2): 724-33.
[http://dx.doi.org/10.21037/tau-20-1056] [PMID: 33718074]
[73]
Hassan A, Dohi T, Miyauchi K, et al. Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2017; 69(6): 830-5.
[http://dx.doi.org/10.1016/j.jjcc.2016.08.013] [PMID: 27692567]
[74]
He T, Jin X, Koh YS, Zhang Q, Zhang C, Liu F. The association of homocysteine, folate, vitamin B12, and vitamin B6 with fracture incidence in older adults: a systematic review and meta-analysis. Ann Transl Med 2021; 9(14): 1143.
[http://dx.doi.org/10.21037/atm-21-2514] [PMID: 34430584]
[75]
Levy J, Rodriguez-Guéant RM, Oussalah A, et al. Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and/or inherited disorders of one-carbon metabolism: a 3.5-year retrospective cross-sectional study of consecutive patients. Am J Clin Nutr 2021; 113(5): 1157-67.
[http://dx.doi.org/10.1093/ajcn/nqaa432] [PMID: 33693455]
[76]
Christen WG, Cook NR, Van Denburgh M, Zaharris E, Albert CM, Manson JE. Effect of combined treatment with folic acid, Vitamin B6, and Vitamin B12 on plasma biomarkers of inflammation and endothelial dysfunction in women. J Am Heart Assoc 2018; 7(11): e008517.
[http://dx.doi.org/10.1161/JAHA.117.008517] [PMID: 29776960]
[77]
Gil APR, Katsa ME. Vitamin B-related gene polymorphisms and cardiovascular disease. Endocr Metab Immune Disord Drug Targets 2022; 22(10): 979-84.
[http://dx.doi.org/10.2174/1381612828666220328115605] [PMID: 35346016]
[78]
Mendonça N, Jagger C, Granic A, et al. Elevated total homocysteine in all participants and plasma vitamin B12 concentrations in women are associated with all-cause and cardiovascular mortality in the very old: The newcastle 85+ study. J Gerontol A Biol Sci Med Sci 2018; 73(9): 1258-64.
[http://dx.doi.org/10.1093/gerona/gly035] [PMID: 29529168]
[79]
Khan MS, Saeedullah A, Andrews SC, et al. Adolescent afghan refugees display a high prevalence of hyperhomocysteinemia and associated micronutrients deficiencies indicating an enhanced risk of cardiovascular disease in later life. Nutrients 2022; 14(9): 1751.
[http://dx.doi.org/10.3390/nu14091751] [PMID: 35565715]
[80]
Khaire A, Rathod R, Kemse N, Kale A, Joshi S. Supplementation with omega-3 fatty acids during gestation and lactation to a vitamin B12-deficient or -supplemented diet improves pregnancy outcome and metabolic variables in Wistar rats. Reprod Fertil Dev 2015; 27(2): 341-50.
[http://dx.doi.org/10.1071/RD13306] [PMID: 24355403]
[81]
Kaplan S, Türk A. Effects of vitamin B12 on rat ovary with ischemia-reperfusion injury. Biotech Histochem 2022; 97(4): 284-9.
[http://dx.doi.org/10.1080/10520295.2021.1961863] [PMID: 34353191]
[82]
Ebesunun MO, Obajobi EO. Elevated plasma homocysteine in type 2 diabetes mellitus: A risk factor for cardiovascular diseases. Pan Afr Med J 2012; 12: 48.
[PMID: 22937188]
[83]
Bhosale UA, Yegnanarayan R, Agrawal A, Patil A. Efficacy study of folic acid supplementation on homocysteine levels in adolescent epileptics taking antiepileptic drugs: A single blind randomized controlled clinical trial. Ann Neurosci 2019; 26(3-4): 50-4.
[http://dx.doi.org/10.1177/0972753120925560] [PMID: 32843833]
[84]
Monasso GS, Santos S, Geurtsen ML, Heil SG, Felix JF, Jaddoe VWV. Associations of early pregnancy and neonatal circulating folate, vitamin b-12, and homocysteine concentrations with cardiometabolic risk factors in children at 10 y of age. J Nutr 2021; 151(6): 1628-36.
[http://dx.doi.org/10.1093/jn/nxab039] [PMID: 33758913]
[85]
Napal LJJ, González BP, Cuesta MA, Caballero AFA, Olmos MJM, Hernández HJL. Lipid profile and serum folate, vitamin B12 and homocysteine levels in patients with retinal vein occlusion. Clin Investig Arterioscler 2021; 33(4): 169-74.
[http://dx.doi.org/10.1016/j.arteri.2020.07.001] [PMID: 33069456]
[86]
Borowczyk K, Piechocka J, Głowacki R, et al. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial. J Intern Med 2019; 285(2): 232-44.
[http://dx.doi.org/10.1111/joim.12834] [PMID: 30193001]
[87]
Li Y, Spence JD, Wang X, Huo Y, Xu X, Qin X. Effect of vitamin b12 levels on the association between folic acid treatment and ckd progression: A post hoc analysis of a folic acid interventional trial. Am J Kidney Dis 2020; 75(3): 325-32.
[http://dx.doi.org/10.1053/j.ajkd.2019.07.020] [PMID: 31629573]
[88]
Jenkins DJA, Spence JD, Giovannucci EL, et al. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. J Am Coll Cardiol 2021; 77(4): 423-36.
[http://dx.doi.org/10.1016/j.jacc.2020.09.619] [PMID: 33509399]
[89]
Debreceni B, Debreceni L. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovasc Ther 2014; 32(3): 130-8.
[http://dx.doi.org/10.1111/1755-5922.12064] [PMID: 24571382]
[90]
Wang Y, Jin Y, Wang Y, et al. The effect of folic acid in patients with cardiovascular disease. Medicine 2019; 98(37): e17095.
[http://dx.doi.org/10.1097/MD.0000000000017095] [PMID: 31517834]
[91]
Duong TV, Wong TC, Su CT, et al. Associations of dietary macronutrients and micronutrients with the traditional and nontraditional risk factors for cardiovascular disease among hemodialysis patients. Medicine 2018; 97(26): e11306.
[http://dx.doi.org/10.1097/MD.0000000000011306] [PMID: 29953017]
[92]
Wu S, Feng P, Li W, et al. Dietary folate, vitamin b6 and vitamin b12 and risk of cardiovascular diseases among individuals with type 2 diabetes: A case-control study. Ann Nutr Metab 2023; 79(1): 5-15.
[http://dx.doi.org/10.1159/000527529] [PMID: 36228591]
[93]
Ingles DP, Cruz Rodriguez JB, Garcia H. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Curr Cardiol Rep 2020; 22(4): 22.
[http://dx.doi.org/10.1007/s11886-020-1270-1] [PMID: 32067177]
[94]
Mitu O, Cirneala IA, Lupsan AI, et al. The effect of vitamin supplementation on subclinical atherosclerosis in patients without manifest cardiovascular diseases: Never-ending hope or underestimated effect? Molecules 2020; 25(7): 1717.
[http://dx.doi.org/10.3390/molecules25071717] [PMID: 32283588]
[95]
Kim HN, Eun YM, Song SW. Serum folate and vitamin B12 levels are not associated with the incidence risk of atherosclerotic events over 12 years: the Korean genome and epidemiology study. Nutr Res 2019; 63: 34-41.
[http://dx.doi.org/10.1016/j.nutres.2018.12.009] [PMID: 30824395]
[96]
Jayedi A, Zargar MS. Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 2019; 59(16): 2697-707.
[http://dx.doi.org/10.1080/10408398.2018.1511967] [PMID: 30431328]
[97]
Woo K, Kwok T, Celermajer D. Vegan diet, subnormal vitamin B-12 status and cardiovascular health. Nutrients 2014; 6(8): 3259-73.
[http://dx.doi.org/10.3390/nu6083259] [PMID: 25195560]
[98]
Lévy S, Santini L, Capucci A, et al. European cardiac arrhythmia society statement on the cardiovascular events associated with the use or abuse of energy drinks. J Interv Card Electrophysiol 2019; 56(1): 99-115.
[http://dx.doi.org/10.1007/s10840-019-00610-2] [PMID: 31482331]
[99]
Al-Musharaf S, McTernan PG, Hussain SD, et al. Prevalence and indicators of vitamin B12 insufficiency among young women of childbearing age. Int J Environ Res Public Health 2020; 18(1): 1.
[http://dx.doi.org/10.3390/ijerph18010001] [PMID: 33374905]
[100]
Abd-Elmawla MA, Rizk SM, Youssry I, Shaheen AA. Impact of genetic polymorphism of methylenetetrahydrofolate reductase c677t on development of hyperhomocysteinemia and related oxidative changes in egyptian β-thalassemia major patients. PLoS One 2016; 11(5): e0155070.
[http://dx.doi.org/10.1371/journal.pone.0155070] [PMID: 27187171]

Rights & Permissions Print Cite
Article Metrics
36
3
© 2024 Bentham Science Publishers | Privacy Policy